University of Dundee
Chronic p53-independent p21 expression causes genomic instability by deregulatingreplication licensingGalanos, Panagiotis; Vougas, Konstantinos; Walter, David; Polyzos, Alexander; Maya-Mendoza, Apolinar; Haagensen, Emma J.Published in:Nature Cell Biology
DOI:10.1038/ncb3378
Publication date:2016
Document VersionPeer reviewed version
Link to publication in Discovery Research Portal
Citation for published version (APA):Galanos, P., Vougas, K., Walter, D., Polyzos, A., Maya-Mendoza, A., Haagensen, E. J., Kokkalis, A., Roumelioti,F-M., Gagos, S., Tzetis, M., Canovas, B., Igea, A., Ahuja, A. K., Zellweger, R., Havaki, S., Kanavakis, E.,Kletsas, D., Roninson, I. B., Garbis, S. D., ... Gorgoulis, V. G. (2016). Chronic p53-independent p21 expressioncauses genomic instability by deregulating replication licensing. Nature Cell Biology, 18(7), 777-789.https://doi.org/10.1038/ncb3378
General rightsCopyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or othercopyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated withthese rights.
• Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain. • You may freely distribute the URL identifying the publication in the public portal.
Take down policyIf you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediatelyand investigate your claim.
Download date: 18. Feb. 2022
b.
p21WAF1 Ki67 DAPI p21WAF1 Ki67
Figure 1 H
ead
&N
eck
Ca
L
un
g C
a
Uro
thel
ial
Ca
Cumulative data
p21WAF1 Ki67 Ki67 p21WAF1 DAPI
p21WAF1 Ki67 p21WAF1 Ki67 DAPI
a.
c.
40% 3.24
45% 1.58
10% 1.22 5% 1.58
39% 3.08
39% 4.30 15% 1.58
7% 2.55
38% 5.05
34% 6.20 19% 4.24
7% 1.58
p21-/ki67+
p21-/ki67-
p21+/ki67-
p21+/ki67+
p21WAF1-/Ki67+
p21WAF1-/Ki67-
p21WAF1+/Ki67-
p21WAF1+/Ki67+ Serial section IHC analysis IF analysis
a.
e.
Figure 2
OFF ON 4d-siCdt1siCdc6 ON 4d
G1
57.97 S
5.99
G2
19.02
>4N
8.89
G1
71.71 S
5.35
G2
17.68
>4N
0.78
b.
G1
29.94
S
26.31
G2
36.59
>4N
0.59
PI
EdU
Li-Fraumeni fibroblasts
(p53mut/null)
-
Cdc6
Cdt1
actin
p21WAF1
+ pBabe p21WAF1
+ - pBabe
actin
Cdc6
HT1080 p21WAF1 –IPTG-ON
(wt p53)
p21WAF1
Cdt1
H1299 p21WAF1 –Ponesterone-ON
(p53null)
actin
Cdc6
p21WAF1
Cdt1
:
:
0d 2d 4d 0d 2d 4d Timeline:
Transcriptomics ProteomicsCDT1
CDC6
ORC1
DNA Replication Licensing
CENPF
INCE
SPDLY
PLK1
KIF23
BUB1B
BOREA
ERC6L
Mitotic Machinery
Strong Overexpression
No Differentiation
Strong Suppression
KIF2C
Saos2 p21WAF1 TetON
OFF ON 96h
+shp53 -shp53
Ap G1 S G2/M
2.53 45.19 17.51 28.25
Ap G1 S G2/M
26.07 55.03 6.06 10.14
Ap G1 S G2/M
4.14 70.54 5.65 15.95
p21WAF1
p53
Cdt1
Cdc6
actin
OFF
-sh
p5
3
+sh
p5
3
ON 96h
HT1080 p21WAF1 –IPTG-ON
Saos2 p21WAF1 TetON
d.
PI PI PI
c.
Cdt1
SET8
actin
p21WAF1
Saos2
0 2 4 6 8 10
% cells with DNA content 4N
OFF
ON 4d
ON 4d-siCdt1/Cdc6
0 10 20 30 40
05
101520253035
<0.2 <0.4 <0.6 <0.8 <1 <1.2 <1.4 <1.6 <2 >2
OFF
ON 4d
CIdU/IdU ratio fork asymmetry
% R
epli
cati
on
fo
rks
OFF ON48h ON 96h
ctl
si
siC
dc6
si
Cd
t1
siC
dc6
+si
Cdt1
Saos2 p21WAF1 TetON
0 hours
24 hours
96 hours
Tail moment (arbitrary units)
Vinculin
Cdc6
Cdt1
p21WAF1
γH2AX
DNA damage
Replication fork asymmetry Replication fork speed
CldU/IdU *p (T-test) n
OFF 1.03 0.24 498
OFF vs ON 4d 1.09 0.36 0.001885 377
Total fork speed:
((CldU+IdU)/40min)
CldU 20min + IdU 20min
OFF ON 4d
0
5
10
15
20
25
30
35
<0.2 <0.4 <0.6 <0.8 <1 <1.2 <1.4 <1.6 <2 <3
OFF
ON 4d
Kb/min
% R
epli
cati
on
fo
rks
CldU kb/min Idu Kb/min Total speed p (T-test) n
OFF 1.16 0.26 1.17 0.33 1.16 0.27 498
ON 4d 0.9 0.43 0.88 0.47 0.89 0.43 7.50E-24 377
OFF+ctl si ON 96h+ctl si
ON 96h
+siCdc6/siCdt1
DA
PI
p2
1W
AF
1
53
BP
1
Mer
ged
Cdc6
Cdt1
p21WAF1
0h 12h 48h 96h
ctl si
48h 96h
siRNAs
0h
actin
γH2AX
siCd
c6
γH2AX
siCd
t1
actin
H2AX
H2AX
Cdc6
γH2AX
H2AX
Cdt1
p21WAF1
siCd
c6+
siCd
t1
No of 53BP1 foci per cell
γH2AX
Ed
U
OΝ 48h
16.42
33.07
38.65
6.42
ON 96h
73.69 0.73
19.70 5.89
OFF
29.56 9.13
53.30 9.01
0
20
40
60
80
100
% o
f E
dU-p
osit
ive
cell
s w
ith
incr
ease
dγH
2AX
OFF
ON48h
ON96h
*
*
OFF+ctl si ON 96h+ctl si OΝ 96h+siCdc6/siCdt1
PI
γH
2A
X
2n 4n 2n 4n
2n 4n
S-phase
0
10
20
30
40
50
% o
f γH
2A
X c
ell
s gate
d in f
ram
e
OFF+ctl si
ON96h+ctl si
ON96h +siCdc6/siCdt1
* *
Figure 3
a. b.
d.
c.
e.
* p < .002
0 10 20 30
OFF+ctl si
ON96h+ctl si
ON96h +siCdc6/siCdt1
0 10 20 30 40
0 10 20 30 40
0 10 20 30 40
0 10 20 30 40
0 10 20 30 40 50
% EdU positive cells with increased γH2AX
Saos2 p21WAF1 TetON
MUS81
actin
p21WAF1
ctl si siMUS81
γH2AX
Ed
U
OFF+ctl si
49,66
45,63
3,19
1,52
ON96h+ctl si
44,18
18,87
33,97
2,99
OΝ96 h+siMUS81
8,45
74,63
4,72
12,20
OFF+ctl si
ON96h+ctl si
ON96h +siMUS81
OFF 96h
ON 96h
ON 96h
ctl
si
ctl
si
siM
US
81
OFF ON96h
Brd
U
p2
1W
AF
1
DA
PI
OFF ON96h
a. b. Non-denaturating conditions
DA
PI
c.
d.
e.
Figure 4
p2
1W
AF
1
0
1
2
3
4
5
6
ON 96h OFF
*
Ra
tio
γH
2A
X/H
2A
X
(arb
itra
ry u
nit
s)
ctl si
siRad51
0
2
4
6
8 *
Ra
tio
γH
2A
X/H
2A
X
(arb
itra
ry u
nit
s)
ctl si
siRad52
g.
E2F4 ChIP
Fo
ld c
ha
ng
e
(arb
itra
ry u
nit
s)
OFF
ON 96h
0
20
40
60
80
100
120
h.
p21WAF1
γH2AX
0 20 40 60
% cells with increased γH2AX
ctl si
siRad52
OFF
ON 96h
γH
2A
X
PI
3,80
OFF
27,84
ON 96h
si ctl
22,05
OFF
45,61
ON 96h
siRad52
γH
2A
X
PI
OFF+ctl si
ON96h+ctl si
ON96h +siMUS81
f.
Rad52
actin
H2AX
ctl
si
ctl
si
siR
ad5
2
siR
ad5
2
OFF ON 96h
ON 96h OFF
OFF ON 96h
85
85
E2F4
input
OFF ON 96h
130
130
NC
input
E2F4 (85bp):
1000Rad51
1000Rad51NC (130bp):
RPA
Rad51
p21WAF1
γH2AX
actin
H2AX
ctl
si
ctl
si
siR
ad5
1
siR
ad5
1
OFF ON 96h
0 10 20 30 40
0 10 20 30 40
OFF 96h ON 96h
siC
dc6
/siC
dt1
ct
r si
si
Cdc6
si
Cdt1
Sao
s2 p
21
WA
F1 T
et-O
N
sip73
% senescent cells
Figure 5
96h
0h
% senescent cells
96h
0h
% senescent cells
OFF
Saos2- p21WAF1
p14ARF
p21WAF1
actin
ON 96h
p16INK4A
a. b.
c.
p21WAF1
actin
p73
p21WAF1
actin
p73
0 10 20 30 40
96h
0h
% senescent cells
96h
0h
% senescent cells
0 10 20 30 40
96h
0h
0 10 20 30 40
0
20
40
60
80
OFF ON 2d ON 4d ON 20d
% B
rdU
inco
rpora
tion
4 d
ays
20 d
ays
ON
20 d
ays
OF
F
DAPI
Escape
p21WAF1 Cyclin A
2 d
ays
Saos2 p21WAF1 Tet-ON
ON 96h
53.33 22.86
1.16 22.65
ON 20 days
28.49 55.63
2.98 12.90
OFF ON (Escape)
20 days
0 50 100
+/-
-/+
+/+
% of CyclinA/p21WAF1 cells
a.
d.
g.
c.
0
0,25
0,5
0,75
1
OFF ON
Nu
clea
r are
a (μ
m2)
0
10
20
30
40
50
60
70
OFF ON 4d ON 20d
% o
f E
dU
/p21
WA
F1
posi
tive
cell
s
p21WAF1
EdU
OFF
55.28 0.24
0.10 44.04
OFF ON 4 d
ays
20
day
s 0 d
ays
2 d
ays
Escape
*
b.
e. f.
Cdk2-pT160
p21WAF1
Cdk2-total
OFF ON 4d ON 20d
actin
p73
j.
Figure 6
0 1 2 3 4 5 6
Normalized TM
OFF
ON 4 d
ON 10 d
ON 20 d
ON 25 d
OFF ON 4 d ON 10 d ON 20 d ON 25 d
DA
PI
p2
1W
AF
1 B
rdU
ON 20 days
% total p21WAF1 cells
% total BrdU/p21WAF1 cells
0
20
40
60
80
100
h.
OF
F
ON
45
d
0 20 40
Number of colonies per 2500 cells
OFF ON 45d
0 1 2
Clone diameter (mm)
0 0,5 1 1,5 2 2,5 3
IC50 (μg/ml)
Taxol Cis-platinum Doxorubicin
OFF
ON 20d
ON 20d +
OFF 10d
i.
0 100 200 300 400
OFF ON 45d
Invasion (% of control)
Novel translocations (N: 103) in “escaped” vs OFF cells
FRA3B
Lo
g2
Rat
io
Large scale loss
Log2R
atio
Figure 7
Chr. 1 Chr. 2 Chr. 3 Chr. 4 Chr. 5 Chr. 6 Chr. 7 Chr. 8 Chr. 9 Chr. 10 Chr. 11 Chr. 12 Chr. 22 Chr. 21 Chr. 20 Chr. 19 Chr. 18 Chr. 17 Chr. 16 Chr. 15 Chr. 14 Chr. 13
Probe gain Probe loss Potential chromoanasynthesis Potential chromothripsis
Chro
moso
mes
5.92 Kbp
20.1 Kbp
8.38 Kbp
14 Kbp
105.4 Kbp 90.64 Kbp 147.42 Kbp
50.05 Kbp
13.67 Kbp
15.06 Kbp
42.98 Kbp
71.89 Kbp 350.66 Kbp 128.18 Kbp
Chr. X
a.
b.
0
10
20
30
40
50
60
70
80N=100 nuclei
OFF
Tota
l N
o o
f m
icro
nucl
ei
ON 30d
c. d.
p53-independent overproduction of p21WAF1/Cip1CRL4Cdt1
SCFSkp2
Cdt1
E2F1/2
+
Cdc6+
Replication Stress: Re-replication DNA damage Rad52 error-prone repair
oversatu
ration
Genomic
Instability
and
Cancer
Progression
e.
Micronuclei in “escaped” cells
aCGH analysis of “escaped” vs OFF cells
Concordance between aCGH and deep sequencing (NGS)
Chromosome 1
NGS aCGH
Chromosome 5
aCGH NGS
Chromosome X
aCGH NGS
Chromosome 8
aCGH NGS